Cargando…
Cost of increasing access to artemisinin combination therapy: the Cambodian experience
BACKGROUND: Malaria-endemic countries are switching antimalarial drug policy from cheap ineffective monotherapies to artemisinin combination therapies (ACTs) for the treatment of Plasmodium falciparum malaria and the global community are considering setting up a global subsidy to fund their purchase...
Autores principales: | Yeung, Shunmay, Van Damme, Wim, Socheat, Duong, White, Nicholas J, Mills, Anne |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2413253/ https://www.ncbi.nlm.nih.gov/pubmed/18492245 http://dx.doi.org/10.1186/1475-2875-7-84 |
Ejemplares similares
-
Access to artemisinin combination therapy for malaria in remote areas of Cambodia
por: Yeung, Shunmay, et al.
Publicado: (2008) -
Optimising Strategies for Plasmodium falciparum Malaria Elimination in Cambodia: Primaquine, Mass Drug Administration and Artemisinin Resistance
por: Maude, Richard J., et al.
Publicado: (2012) -
Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia
por: Yeung, Shunmay, et al.
Publicado: (2011) -
Laboratory Detection of Artemisinin-Resistant Plasmodium falciparum
por: Chotivanich, Kesinee, et al.
Publicado: (2014) -
The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia
por: Maude, Richard J, et al.
Publicado: (2009)